Merck & Co. (MRK)
(Delayed Data from NYSE)
$131.95 USD
+0.20 (0.15%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $131.94 -0.01 (-0.01%) 6:44 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/25/2024
Time: BMO |
3/2024 | $2.12 | 1.63% |
Earnings Summary
For their last quarter, Merck & Co. (MRK) reported earnings of $0.03 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 133.33%. Look out for MRK's next earnings release on April 25, 2024. For the next earning release, we expect the company to report earnings of $2.12 per share, reflecting a year-over-year increase of 51.43%.
Earnings History
Price & Consensus
Zacks News for MRK
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services